Finance

Lists
AGN:ASX
Argenica Therapeutics Ltd
0,12 AUD
0,00%
(0,00) 1D
12-окт., 10:00:47 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AGN...
Mkt. cap
16,06 млн
Avg. vol.
66,89 миң
Volume
0,00
52-wk high
0,34 AUD
52-wk low
0,09 AUD
EPS
-0,01 AUD
Shares outstanding
128,46 млн
Mkt. cap
16,06 млн
Avg. vol.
66,89 миң
Volume
0,00
52-wk high
0,34 AUD
52-wk low
0,09 AUD
EPS
-0,01 AUD
Shares outstanding
128,46 млн
News stories
From web sources and news partners
About Argenica Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 24-июл.
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
2,43 млн / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
313,37 миң
313,37 миң
2,43 млн
2,43 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 млн
1,52 млн
588,41 миң
588,41 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
739,40 миң
739,40 миң
643,55 миң
643,55 миң
Operating expense
2,27 млн
2,27 млн
1,26 млн
1,26 млн
Total operating expenses
2,27 млн
2,27 млн
1,26 млн
1,26 млн
Operating income
-1,96 млн
-1,96 млн
1,17 млн
1,17 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,91 млн
-1,91 млн
1,23 млн
1,23 млн
EBT excluding unusual items
-1,91 млн
-1,91 млн
1,23 млн
1,23 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
26,46 миң
26,46 миң
Net income
-1,91 млн
-1,91 млн
1,23 млн
1,23 млн
Net profit margin
-609,00%
-609,00%
50,46%
50,46%
Earnings per share
-
-
-
-
Interest and investment income
46,72 миң
46,72 миң
59,29 миң
59,29 миң
Interest expense
-94,00
-94,00
-63,00
-63,00
Net interest expenses
46,62 миң
46,62 миң
59,23 миң
59,23 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору